
Join to View Full Profile
5323 Harry Hines BoulevardDallas, TX 75390
Phone+1 214-645-4673
Fax+1 214-645-2615
Dr. Drapkin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2013 - 2017
- Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2010 - 2013
- Weill Cornell MedicineClass of 2010
Certifications & Licensure
- TX State Medical License 2020 - 2027
- MA State Medical License 2018 - 2021
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 2 citationsIntrinsic electrical activity drives small-cell lung cancer progression.Paola Peinado, Marco Stazi, Claudio Ballabio, Michael-Bogdan Margineanu, Zhaoqi Li
Nature. 2025-03-01 - KSR1 mediates small-cell lung carcinoma tumor initiation and cisplatin resistance.Deepan Chatterjee, Robert A Svoboda, Dianna H Huisman, Benjamin J Drapkin, Heidi M Vieira
Molecular Cancer Research. 2025-02-10 - Atypical Small Cell Lung Cancer: A New Malignancy Characterized by Chromothripsis, Carcinoid Tumors, and Wild-type RB1 and TP53.Urooba Nadeem, Benjamin J Drapkin
Cancer Discovery. 2025-01-13
Press Mentions
- Lung Cancer Treatment Shows Promise in Tumor ModelsMarch 12th, 2024
Grant Support
- Acquired Cross-Resistance through MYC Amplification in Small Cell Lung CancerUT SOUTHWESTERN MEDICAL CENTER2025–2029
- Acquired Cross-Resistance through MYC Amplification in Small Cell Lung CancerUT SOUTHWESTERN MEDICAL CENTER2025–2029
- Dissecting and overcoming cross-resistance to DNA damaging agents in SCLCUT SOUTHWESTERN MEDICAL CENTER2020–2025
- Dissecting and overcoming cross-resistance to DNA damaging agents in SCLCUT SOUTHWESTERN MEDICAL CENTER2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: